Home
Resources
Publications
An Update on Pulmonary and Neurodevelopmental Outcomes of Bronchopulmonary Dysplasia

An Update on Pulmonary and Neurodevelopmental Outcomes of Bronchopulmonary Dysplasia

Jeanie L Y Cheong, Lex W Doyle

Semin Perinatol. 2018 Nov;42(7):478-484.

PMID: 30401478

Abstract:

Bronchopulmonary dysplasia (BPD) is a common complication of extreme prematurity, and its rate is not improving, despite advances in perinatal intensive care. Children with BPD diagnosed in the neonatal period have higher risks for hospitalizations for respiratory problems over the first few years of life, and they have more asthma in later childhood. Neonates diagnosed with BPD have substantial airway obstruction on lung function testing in later childhood and early adulthood, and many are destined to develop adult chronic obstructive pulmonary disease. Survivors with neonatal BPD have more adverse motor function, worse cognitive development and poorer academic progress than those without BPD. Long-term outcomes for children born extremely preterm will improve if the rate of BPD can be substantially reduced.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP213481120	BPD		213481-12-0	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: